Atrophic hypothyroidism associated with thyrotropin receptor antibodies.
Authors:
- Marcos Tadashi Kakitani ToyoshimaMTMarcos Tadashi Kakitani Toyoshima
- Camila Regina Pereira Batista de MacedoCMCamila Regina Pereira Batista de Macedo
- Isabelle Pinheiro Amaro de MagalhaesIMIsabelle Pinheiro Amaro de Magalhaes
- Janaina Almeida de SouzaJSJanaina Almeida de Souza
- Giulianno Dias da RochaGRGiulianno Dias da Rocha
- Suemi MaruiSMSuemi Marui
Open Access
- 1 September 2025
- journal article
- case report
- Vol. 23, eRC1400
Abstract
Hypothyroidism is most frequently caused by Hashimoto's thyroiditis. While thyrotropin receptor antibodies are well-known in Graves' disease-induced hyperthyroidism, their role in hypothyroidism is emerging. We report the case of a 37-year-old woman with facial and periorbital edema, weight gain, and hoarseness suggestive of hypothyroidism. Elevated thyroid stimulating hormone (TSH; 131mIU/L) and decreased free thyroxine (0.2ng/dL, 2.6pmol/L) levels confirmed this diagnosis. Laboratory findings showed dyslipidemia, impaired renal function, elevated creatine phosphokinase levels, and anemia. Despite negative results for thyroid peroxidase (TPO-Ab) and thyroglobulin (TgAb) antibodies, positive thyrotropin receptor antibodies (11IU/L) suggested an autoimmune etiology. Thyroid ultrasound confirmed atrophic thyroiditis. Levothyroxine treatment improved the symptoms and laboratory values. Two months after diagnosis, the patient became pregnant. Anemia relapsed during pregnancy, thyrotropin receptor antibodies levels normalized, and postpartum follow-up revealed stable thyroid function without affecting the newborn thyroid function. This case underscores the diagnostic challenges of negative TPOAb and TgAb hypothyroidism, which is often misdiagnosed as Hashimoto's thyroiditis, and highlights the need for functional discrimination in thyrotropin receptor antibodies assays. Thyrotropin receptor antibodies measurements can help in the differential diagnosis of rapidly evolving hypothyroidism in women with negative TPO-Ab and thyrotropin receptor antibodies levels, especially in women of childbearing age. Further research is essential to understand thyrotropin-binding inhibitory immunoglobulin-mediated hypothyroidism and to develop targeted therapies.Keywords
This publication has 14 references indexed in Scilit:
- Thyrotropin Receptor Blocking AntibodiesHormone and Metabolic Research, 2018
- Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal DiseasesFrontiers in Immunology, 2017
- A baby with congenital hypothyroidism born to a hypothyroid mother who expressed undiagnosed thyroid stimulation blocking antibodyAnnals of Pediatric Endocrinology & Metabolism, 2016
- Clinical Utility of TSH Receptor AntibodiesThe Journal of Clinical Endocrinology & Metabolism, 2013
- Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves’ Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive PatientsJournal of Thyroid Research, 2012
- Neutral Antibodies to the TSH Receptor Are Present in Graves’ Disease and Regulate Selective Signaling CascadesEndocrinology, 2010
- On the pathogenesis of autoimmune thyroid disease: a unifying hypothesisClinical Endocrinology, 2004
- Chronic Autoimmune ThyroiditisNew England Journal of Medicine, 1996
- Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies.The Journal of Clinical Endocrinology & Metabolism, 1996
- Fetal and Neonatal Hyperthyroidism and Hypothyroidism due to Maternal TSH Receptor AntibodiesThyroid®, 1992